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Abstract
Background: The provision of antiretroviral therapy (ART) to migrant populations raises particular challenges with respect
to ensuring adequate treatment support, adherence, and retention in care. We assessed rates of loss to follow-up for
migrant workers compared with non-migrant workers in a routine treatment programme in Morjia, Lesotho.
Design: All adult patients ($18 years) initiating ART between January 1, 2008, and December 31, 2008, and followed up
until the end of 2009, were included in the study. We described rates of loss to follow-up according to migrant status by
Kaplan-Meier estimates, and used Poisson regression to model associations between migrant status and loss to follow-up
controlling for potential confounders identified a priori.
Results: Our cohort comprised 1185 people, among whom 12% (148) were migrant workers. Among the migrant workers,
median age was 36.1 (29.6–45.9) and the majority (55%) were male. We found no statistically significant differences between
baseline characteristics and migrant status. Rates of lost to follow up were similar between migrants and non-migrants in
the first 3 months but differences increased thereafter. Between 3 and 6 months after initiating antiretroviral therapy,
migrants had a 2.78-fold increased rate of defaulting (95%CI 1.15–6.73); between 6 and 12 months the rate was 2.36 times
greater (95%CI 1.18–4.73), whereas after 1 year the rate was 6.69 times greater (95%CI 3.18–14.09).
Conclusions: Our study highlights the need for programme implementers to take into account the specific challenges that
may influence continuity of antiretroviral treatment and care for migrant populations.
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Introduction
Lesotho (population 1.8 million) is a resource-limited country
with a per capita income estimated at $1541 in 2007 [1]. The
country’s economy is highly dependent on remittances from
migrant labourers, mainly temporary mine workers or domestic
servants who work in neighbouring South Africa for up to 3
months at a time. Around a third of adult males are estimated to
have worked in the mines in South Africa, and migrant workers
are thought to account for up to two-thirds of Lesotho’s gross
domestic product [1,2].
This high dependency on migrant labour has contributed
substantially to the country’s HIV epidemic. Lesotho has the third
highest HIV prevalence in the world (adult prevalence estimated
at 23%) [3], mainly due to vulnerabilities associated with migrant
labour such as overcrowded living and working conditions, and
long periods away from home leading to disruption of social
networks and potential increases in risky behaviours such as
alcohol abuse and multiple sexual partners [4,5].
In 2006, the government of Lesotho embarked on a national
programme for the scaling up of treatment and care for people
living with HIV/AIDS [6]. Among the many challenges associated
withwidespreadaccesstoHIV/AIDScareinLesotho,the provision
of treatment and care to mobile populations such as migrant
workers poses particular challenges. Barriers to care for migrants
include access to health services and social support in the host
country, discrimination, limited ability to take sick leave, and stigma
associated with taking medicine at work [7]. The provision of
antiretroviral therapy (ART) in particular raises concerns with
respect to ensuring adequate treatment support, adherence, and
retention in care. International organisations have highlighted the
need to ensure adequate access to prevention, treatment, and care
for migrant workers since 2002 [8], but there are few documented
outcomes from ART programmes supporting migrant populations.
Me ´decins Sans Frontie `res (MSF) has been supporting HIV
treatment and care in two districts in Lesotho since 2006. Around
12% of patients in the programme are migrant workers. A rapid
survey carried out among a non-random selection of defaulters in
2009 found that the most common reason for defaulting was
migration to South Africa for work [3]. We assessed the rates of
loss to follow-up for migrant workers compared with non-migrant
workers.
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Programme setting
MSF and Lesotho’s Ministry of Health and Social Welfare
established a primary care HIV/AIDS programme in the Scott
Catchment Area in 2006. Antiretroviral therapy is provided across
14 primary care health centres and one district hospital. A policy
of early initiation of ART was adopted by the government of
Lesotho in late 2007 [9]. Patients attend the clinic on a monthly
basis for medical check up and ART refills. In exceptional
circumstances patients (usually migrant workers) can be given
ART supplies for up to 3 months.
Data collection
Three clinicians extracted data from clinic paper-based registers
into an Access database, and this was then exported into STATA
(version 11) for analysis. Adult patients ($18 years) initiating
antiretroviral therapy between January 1, 2008, and December 31,
2008,were includedinthe analysis,and followedup untilthe end of
2009. Patients were categorised as migrant worker or non-migrant
worker according to information collected at treatment initiation:
migrants were defined as anyone who crossed to South Africa for
the purposes of work (in this context, this included mainly miners,
contract workers, and domestic servants). Patients were defined as
lost to follow-up if they had not visited a clinic for at least 3 months
at the end of the observation period, consistent with common
definitions for loss to follow-up in ART programmes. The potential
for individuals to return to care (ie, re-enter the cohort) and being
counted twice was avoided by taking a thorough treatment history
from patients on return, and also the fact that clinicsare small (1185
patients across 15 health facilities) and patients are well-known to
nurses and lay counsellors.
Statistical analysis
Categorical variables were summarised by percentages and
frequencies, and continuous variables by medians and interquar-
tile ranges (IQR). Proportions were compared using the x
2 and
Fisher’s exact test. We described rates of loss to follow-up
according to migrant status by Kaplan-Meier estimates
(Figure 1), and used Poisson regression to model the association
between migrant status and loss to follow-up or death. Endpoints
considered for the survival analysis were loss to follow-up, death,
transfer, or study end. The Poisson model used Lexis expansion
splitting time into 0–3 months, 3–6 months, 6–12 months, and
more than 12 months on ART, and was controlled for the
following potential confounders identified a priori: age (#40 or
.40 years), sex, baseline CD4 (#200 cells/mm
3 or .200 cells/
mm
3), and TB at initiation. All reported p values are exact and 2-
tailed, and for each analysis p,0.05 was considered significant.
The analysis was approved by MSF’s independent Ethics
Review Board [10]. Individual patient consent was not sought
because the analysis was based on routine clinical data. All patient
information was entered into the database using coded identifi-
cation numbers, and no information that could reveal patient
identity was entered into the database.
Results
Our cohort comprised 1185 people, of whom 12% (148) were
migrant workers. Among the migrant workers, median age was
36.1 (IQR 29.6–45.9) and the majority (55%) were male. Baseline
CD4 was slightly lower in migrant workers than in the general
population (205 vs 212 cells/mm
3) but this difference was not
statistically significant (p=0.70) (Table 1).
After controlling for age, sex, CD4 count at initiation, and TB
at initiation, we found that the rates of lost to follow-up were
similar for migrant workers and non-migrant workers in the first 3
months, but rates among migrants increased thereafter. Between 3
and 6 months after initiating ART, migrants had a 2.78-fold
increased rate of defaulting (95%CI 1.15–6.73); between 6 and 12
months the rate was 2.36 times greater (95%CI 1.18–4.73);
whereas after 1 year the rate was 6.69 times greater (95%CI 3.18–
14.09) (Table 2).
Discussion
Our study found a relatively low rate of defaulting among
migrant workers compared to the general population in the first
year of treatment, with significant differences observed after one
year. Although mobility is recognised as a reason why patients
drop out of care [11], we were unable to find other published
reports on rates of defaulting among migrant workers on ART for
comparison.
Defaulter tracing studies are not conducted routinely in the
Lesotho programme, so we are unable to report on the reasons for
defaulting. However, one plausible explanation put forward by
staff working in the programme is that patients feel less sick and so
are able to return to work in South Africa (the ‘‘healthy migrant’’
effect).
There are several limitations to our study. First, outcomes in
patients defaulting treatment is unknown. Patients lost to follow up
are known to include both those who have sustained an
unfavourable outcome (non-access to care, and resulting illness
and death) [12], and those whose outcome may be favourable (for
example transferring to a more convenient health facility) [13].
The potential for migrant workers to self-transfer to health services
in South Africa is unclear. South Africa revised its legislation to
allow access to antiretrovirals to foreigners in 2008 [14], but this is
reported to be unevenly applied at the health facilities [15]. In
areas where migrants are able to access health services in South
Africa, outcomes have been highly satisfactory [16]. An additional
challenge relates to the lack of harmonisation in treatment
guidelines: while Lesotho has recommended a tenofovir-based
first-line regimen since late 2007 [17], at the time of our study
South African guidelines recommended a stavudine-based first-
line treatment regimen (this was revised in 2010). Another
limitation, common to all observational studies, is the potential
for residual confounding which might have influenced our effect
estimate. A further limitation is that we did we did not assess
mortality between groups; several deaths will inevitably have
occurred among patients lost to follow-up [12], and given the
substantial difference in follow-up rates between groups, we
considered that any mortality estimate would likely be subject to
substantial bias due to misclassification of mortality among
patients lost to follow up. We also note that a minority of patients
were provided with 3 months’ supply of ART. Because our
definition of loss to follow-up remained consistent for all patients, a
stricter definition was applied to those patients provided with 3-
monthly ART (they had only to miss one appointment to be
classified as lost to follow-up). We do not consider this would have
an important effect since the number of patients provided with 3-
monthly ART was small, and this group received additional
counselling that stressed the importance of returning to the clinic
for ART refills every quarter. Finally, as with all defaulting studies,
there is potential that some of the patients considered lost to
follow-up will return to care (ie, they will in fact have interrupted
their treatment). Although we did not note any instances of
treatment interruption, this might be due to the short follow up
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Africa the median time of interruption was 228 days [18].
The challenge of ensuring continuity of care for migrant
workers has gained increasing attention. In 2009, the Southern
African Development Community (SADC) developed a Policy
Framework for Population Mobility and Communicable Diseases
in the region [19]. The framework identifies a number of
challenges for migrant’s access health care, including: substantially
higher fees for non-nationals; no information as to where services
are provided; reluctance among health care providers to provide
treatment for communicable diseases requiring long treatment
such as TB or AIDS diagnosed in a foreign country; and differing
treatment protocols in the different countries [19]. These concerns
have been reiterated at the international level: the International
Organization for Migration has called for increased measures to
ensure access to HIV prevention, treatment, care, and support
services are made available for migrant workers by both countries
of origin and countries of destination [20].
However, the fact that migrant workers find work in the mines
of South Africa poses a significant challenge, since many of the
migrant workers are undocumented and find their work in the
mines through contractors. The precarious legal status of many of
the workers poses an additional barrier to accessing health
facilities. Additionally, there are serious gaps in the implementa-
Figure 1. Cumulative hazard estimate for being lost to follow up.
doi:10.1371/journal.pone.0013198.g001
Table 1. Characteristics of migrant and non-migrant patients attending ART services.
Total patients (n=1185) Migrant (n=148) Non-migrant (n=1,037) p-value
CD4, median (IQR)* 211 (119–284) 205 (94–297) 212 (120–284) 0.70
Sex, n (%) Female 798 (67%) 66 (45%) 732 (70.6%) ,0.0001
Male 387 (33%) 82 (55%) 305 (29.4%)
Age, median (IQR) 39.1 (29.5–48.2) 36.1 (29.6–45.9) 39.2 (31.1–49.7) 0.03
Pregnant at initiation** Yes 82 (11.6) 3 (4.6%) 79 (10.8%) ,0.0001
No 653 (88.4%) 63 (95.4%) 653 (89.2%)
TB at initiation Yes 198 (16.7%) 198 (16.7%) 168 (16.2%) 0.21
No 987 (83.3%) 118 (79.7%) 869 (83.8%)
Baseline Regimen Tenofovir 607 (51.2%) 100 (67.6%) 507 (48.9%) ,0.0001
Zidovudine 266 (22.5%) 21 (14.2%) 245 (23.6%)
Stavudine 312 (26.3%) 27 (18.2%) 285 (27.5%)
*data missing for 48 patients.
**denominator includes only women.
doi:10.1371/journal.pone.0013198.t001
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been reported that the gold mining industry has a TB incidence
rate up to ten times higher the national incidence rate [21].
SADC has developed a number of policy recommendations to
address these challenges of communicable diseases among mobile
populations [19]. These include regional harmonisation of drug
regimens; coordinated cross border referral services; equitable
access to services for mobile populations; coordinated regional
public health surveillance and epidemic preparedness; informa-
tion, education, and health promotion; and operational research
on the specific vulnerabilities facing mobile populations. To
support these recommendations, the SADC secretariat proposes a
number of legal reforms including the protection of foreign
workers in high-risk work environments such as mining and
agriculture by minimising unfair labour practices and improving
work and living conditions. The AIDS Rights Alliance of South
Africa (a patient advocacy group) takes these recommendations a
step further by calling for the strengthening of existing pro-
grammes for the prevention, diagnosis, and treatment of TB and
HIV among Basotho mineworkers in South Africa [21]. This
would require the private sector to better fulfil its obligations.
Based on the MSF experience of treating mobile populations in
conflict-affected settings several practical recommendations can be
added. These include: providing drug supplies of up to 3 months
for stable patients; adapting adherence counselling to ensure
patients are aware of the importance of uninterrupted treatment;
developing links with treatment providers in South Africa; and
issuing patient-held clinical cards summarising the most important
treatment history in case of unplanned self-transfer [22].
In conclusion, our study shows that providing antiretroviral
therapy to migrant workers is feasible, and highlights the need for
adapted models of care for migrant populations to ensure
continuity of antiretroviral therapy. Such support should extend
beyond the early phase of antiretroviral treatment initiation which
in general populations is considered as the risk period for
defaulting from care.
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